YC W19
Intact Therapeutics
Smart gels for local drug delivery to the gut
About
Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.
Founders
- Ravi Pamnani
- Sidhartha Sinha
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Intact Therapeutics.
See family office activityIndustry & Focus
HealthcareTherapeuticsDrug Delivery